newsfilter
← Latest News
PR Newswire·

AbbVie Completes Acquisition of Cerevel Therapeutics

AbbVie (NYSE: ABBV) today announced that it has completed its acquisition of Cerevel Therapeutics (NASDAQ: CERE). With the completion of the...